http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017112951-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef424f5c42516b7b4409976da5106fd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5129e56b04007883a5eb50113bc1ddb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e36f68704f0c47749d0c442b6268c8bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_06e5d40f3ea4063fd05eef14b47c6d19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7351566dcbd687e9e576a8bda5d942ba
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1045
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-10
filingDate 2015-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88caff3f44bf8a272a16111f0747fe4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e8763e5b5893a86b595154a40d08b26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f847afbb8f4eb7f8e2911e45722f6a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_634e60c4b24647f9e32242eb7d2663e7
publicationDate 2017-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2017112951-A1
titleOfInvention One-Step Labeling of Antibodies to High Specific Activity with Actinium-225
abstract Provided herein is a one-step method for chelating actinium-225 to a construct comprising a chelator linked to a bio-molecule, such as, an antibody or monoclonal antibody, via a bifunctional ligand in, for example, a 3-arm configuration. Also provided are methods for increasing the radiochemical yield of an actinium-225-chelant-biomolecule complex and for producing a high specific activity actinium-225 complex. The chelation is performed at a physiological temperature, about 37° C. Also provided are high specific activity actinium-225 complexes, that is, actinium-225 chelated to the chelator-biomolecule construct and pharmaceutical compositions thereof. Further provided are methods of treating a neoplastic disease or disorder with the actinium-225 complexes.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020113047-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11191778-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10441607-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022216965-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111263747-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3886921-A4
priorityDate 2014-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012009121-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011117014-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226565556
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10143607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226481187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226508434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226648516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10123265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87083399
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226593983

Total number of triples: 51.